nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—CYP2E1—Dacarbazine—sarcoma	0.154	0.289	CbGbCtD
Rufinamide—CYP2E1—Mitoxantrone—sarcoma	0.12	0.224	CbGbCtD
Rufinamide—CYP3A4—Thiotepa—sarcoma	0.0843	0.158	CbGbCtD
Rufinamide—CYP2E1—Etoposide—sarcoma	0.0754	0.141	CbGbCtD
Rufinamide—CYP3A4—Mitoxantrone—sarcoma	0.0362	0.068	CbGbCtD
Rufinamide—CYP3A4—Vincristine—sarcoma	0.0249	0.0468	CbGbCtD
Rufinamide—CYP3A4—Etoposide—sarcoma	0.0228	0.0429	CbGbCtD
Rufinamide—CYP3A4—Doxorubicin—sarcoma	0.0156	0.0292	CbGbCtD
Rufinamide—CES1—larynx—sarcoma	0.0102	0.154	CbGeAlD
Rufinamide—GRM5—hematopoietic system—sarcoma	0.00513	0.0773	CbGeAlD
Rufinamide—SCN7A—myometrium—sarcoma	0.00377	0.0568	CbGeAlD
Rufinamide—GRM5—testis—sarcoma	0.00281	0.0424	CbGeAlD
Rufinamide—SCN7A—cardiac atrium—sarcoma	0.00246	0.0371	CbGeAlD
Rufinamide—ALB—mammary gland—sarcoma	0.00231	0.0348	CbGeAlD
Rufinamide—CES1—hematopoietic system—sarcoma	0.00202	0.0305	CbGeAlD
Rufinamide—SCN2A—hematopoietic system—sarcoma	0.002	0.0302	CbGeAlD
Rufinamide—CES1—connective tissue—sarcoma	0.00195	0.0293	CbGeAlD
Rufinamide—SCN10A—hematopoietic system—sarcoma	0.00193	0.0291	CbGeAlD
Rufinamide—SCN7A—testis—sarcoma	0.00178	0.0267	CbGeAlD
Rufinamide—SCN9A—tendon—sarcoma	0.00168	0.0253	CbGeAlD
Rufinamide—SCN7A—liver—sarcoma	0.00168	0.0253	CbGeAlD
Rufinamide—SCN8A—testis—sarcoma	0.00158	0.0238	CbGeAlD
Rufinamide—SCN4A—tendon—sarcoma	0.0015	0.0226	CbGeAlD
Rufinamide—CES1—lymphoid tissue—sarcoma	0.00142	0.0214	CbGeAlD
Rufinamide—SCN9A—testis—sarcoma	0.00139	0.021	CbGeAlD
Rufinamide—SCN10A—lymphoid tissue—sarcoma	0.00136	0.0205	CbGeAlD
Rufinamide—SCN5A—cardiac atrium—sarcoma	0.00133	0.0201	CbGeAlD
Rufinamide—SCN7A—lymph node—sarcoma	0.00129	0.0194	CbGeAlD
Rufinamide—SCN4A—testis—sarcoma	0.00124	0.0187	CbGeAlD
Rufinamide—SCN3A—tendon—sarcoma	0.00117	0.0176	CbGeAlD
Rufinamide—Bone disorder—Doxorubicin—sarcoma	0.00115	0.00501	CcSEcCtD
Rufinamide—Vision blurred—Thiotepa—sarcoma	0.00115	0.005	CcSEcCtD
Rufinamide—Coordination abnormal—Epirubicin—sarcoma	0.00115	0.00498	CcSEcCtD
Rufinamide—Pneumonia—Etoposide—sarcoma	0.00113	0.00491	CcSEcCtD
Rufinamide—Anaemia—Thiotepa—sarcoma	0.00113	0.00491	CcSEcCtD
Rufinamide—SCN3A—bone marrow—sarcoma	0.00113	0.017	CbGeAlD
Rufinamide—Infestation NOS—Etoposide—sarcoma	0.00112	0.00488	CcSEcCtD
Rufinamide—Infestation—Etoposide—sarcoma	0.00112	0.00488	CcSEcCtD
Rufinamide—Agitation—Thiotepa—sarcoma	0.00112	0.00488	CcSEcCtD
Rufinamide—Nocturia—Doxorubicin—sarcoma	0.00112	0.00488	CcSEcCtD
Rufinamide—Mediastinal disorder—Vincristine—sarcoma	0.00112	0.00487	CcSEcCtD
Rufinamide—Anaemia—Dactinomycin—sarcoma	0.00112	0.00487	CcSEcCtD
Rufinamide—CES1—testis—sarcoma	0.00111	0.0167	CbGeAlD
Rufinamide—Leukopenia—Thiotepa—sarcoma	0.00109	0.00475	CcSEcCtD
Rufinamide—Mental disorder—Vincristine—sarcoma	0.00109	0.00474	CcSEcCtD
Rufinamide—Leukopenia—Dactinomycin—sarcoma	0.00109	0.00472	CcSEcCtD
Rufinamide—Gait disturbance—Doxorubicin—sarcoma	0.00107	0.00464	CcSEcCtD
Rufinamide—Hepatobiliary disease—Etoposide—sarcoma	0.00106	0.00461	CcSEcCtD
Rufinamide—Coordination abnormal—Doxorubicin—sarcoma	0.00106	0.00461	CcSEcCtD
Rufinamide—Convulsion—Thiotepa—sarcoma	0.00106	0.0046	CcSEcCtD
Rufinamide—Back pain—Vincristine—sarcoma	0.00105	0.00455	CcSEcCtD
Rufinamide—CES1—liver—sarcoma	0.00105	0.0158	CbGeAlD
Rufinamide—Anxiety—Thiotepa—sarcoma	0.00104	0.0045	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00103	0.00449	CcSEcCtD
Rufinamide—Back pain—Mitoxantrone—sarcoma	0.00102	0.00443	CcSEcCtD
Rufinamide—SCN9A—lymph node—sarcoma	0.00101	0.0152	CbGeAlD
Rufinamide—Anaemia—Vincristine—sarcoma	0.001	0.00435	CcSEcCtD
Rufinamide—Urinary tract disorder—Etoposide—sarcoma	0.000996	0.00433	CcSEcCtD
Rufinamide—Agitation—Vincristine—sarcoma	0.000996	0.00433	CcSEcCtD
Rufinamide—Vision blurred—Mitoxantrone—sarcoma	0.000995	0.00432	CcSEcCtD
Rufinamide—Infection—Thiotepa—sarcoma	0.000991	0.0043	CcSEcCtD
Rufinamide—Urethral disorder—Etoposide—sarcoma	0.000989	0.00429	CcSEcCtD
Rufinamide—Infection—Dactinomycin—sarcoma	0.000984	0.00427	CcSEcCtD
Rufinamide—Nervous system disorder—Thiotepa—sarcoma	0.000978	0.00425	CcSEcCtD
Rufinamide—Thrombocytopenia—Thiotepa—sarcoma	0.000977	0.00424	CcSEcCtD
Rufinamide—Anaemia—Mitoxantrone—sarcoma	0.000976	0.00424	CcSEcCtD
Rufinamide—Vertigo—Vincristine—sarcoma	0.000974	0.00423	CcSEcCtD
Rufinamide—Leukopenia—Vincristine—sarcoma	0.00097	0.00421	CcSEcCtD
Rufinamide—Thrombocytopenia—Dactinomycin—sarcoma	0.000969	0.00421	CcSEcCtD
Rufinamide—Skin disorder—Thiotepa—sarcoma	0.000969	0.00421	CcSEcCtD
Rufinamide—SCN3A—testis—sarcoma	0.000965	0.0145	CbGeAlD
Rufinamide—Lymphadenopathy—Epirubicin—sarcoma	0.000958	0.00416	CcSEcCtD
Rufinamide—Anorexia—Thiotepa—sarcoma	0.000951	0.00413	CcSEcCtD
Rufinamide—Leukopenia—Mitoxantrone—sarcoma	0.000945	0.0041	CcSEcCtD
Rufinamide—Anorexia—Dactinomycin—sarcoma	0.000944	0.0041	CcSEcCtD
Rufinamide—Eye disorder—Etoposide—sarcoma	0.000943	0.00409	CcSEcCtD
Rufinamide—Convulsion—Vincristine—sarcoma	0.000939	0.00408	CcSEcCtD
Rufinamide—Cardiac disorder—Etoposide—sarcoma	0.000936	0.00407	CcSEcCtD
Rufinamide—Convulsion—Mitoxantrone—sarcoma	0.000915	0.00397	CcSEcCtD
Rufinamide—Immune system disorder—Etoposide—sarcoma	0.000911	0.00396	CcSEcCtD
Rufinamide—Mediastinal disorder—Etoposide—sarcoma	0.000909	0.00395	CcSEcCtD
Rufinamide—Anxiety—Mitoxantrone—sarcoma	0.000896	0.00389	CcSEcCtD
Rufinamide—Somnolence—Thiotepa—sarcoma	0.000887	0.00385	CcSEcCtD
Rufinamide—Lymphadenopathy—Doxorubicin—sarcoma	0.000886	0.00385	CcSEcCtD
Rufinamide—Infection—Vincristine—sarcoma	0.000879	0.00382	CcSEcCtD
Rufinamide—Dyspepsia—Thiotepa—sarcoma	0.000878	0.00381	CcSEcCtD
Rufinamide—CYP2E1—seminal vesicle—sarcoma	0.000875	0.0132	CbGeAlD
Rufinamide—Increased appetite—Epirubicin—sarcoma	0.00087	0.00378	CcSEcCtD
Rufinamide—Nervous system disorder—Vincristine—sarcoma	0.000867	0.00377	CcSEcCtD
Rufinamide—Decreased appetite—Thiotepa—sarcoma	0.000867	0.00377	CcSEcCtD
Rufinamide—Thrombocytopenia—Vincristine—sarcoma	0.000866	0.00376	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Thiotepa—sarcoma	0.000861	0.00374	CcSEcCtD
Rufinamide—Decreased appetite—Dactinomycin—sarcoma	0.000861	0.00374	CcSEcCtD
Rufinamide—Fatigue—Thiotepa—sarcoma	0.00086	0.00374	CcSEcCtD
Rufinamide—Infection—Mitoxantrone—sarcoma	0.000856	0.00372	CcSEcCtD
Rufinamide—Fatigue—Dactinomycin—sarcoma	0.000854	0.00371	CcSEcCtD
Rufinamide—Constipation—Thiotepa—sarcoma	0.000853	0.0037	CcSEcCtD
Rufinamide—Back pain—Etoposide—sarcoma	0.000849	0.00369	CcSEcCtD
Rufinamide—Thrombocytopenia—Mitoxantrone—sarcoma	0.000843	0.00366	CcSEcCtD
Rufinamide—Anorexia—Vincristine—sarcoma	0.000843	0.00366	CcSEcCtD
Rufinamide—Skin disorder—Mitoxantrone—sarcoma	0.000837	0.00363	CcSEcCtD
Rufinamide—CYP2E1—hematopoietic system—sarcoma	0.000832	0.0125	CbGeAlD
Rufinamide—Anorexia—Mitoxantrone—sarcoma	0.000821	0.00357	CcSEcCtD
Rufinamide—Diplopia—Epirubicin—sarcoma	0.000817	0.00355	CcSEcCtD
Rufinamide—Anaemia—Etoposide—sarcoma	0.000811	0.00352	CcSEcCtD
Rufinamide—Increased appetite—Doxorubicin—sarcoma	0.000805	0.0035	CcSEcCtD
Rufinamide—CES1—lymph node—sarcoma	0.000803	0.0121	CbGeAlD
Rufinamide—Insomnia—Vincristine—sarcoma	0.0008	0.00347	CcSEcCtD
Rufinamide—Vertigo—Etoposide—sarcoma	0.000789	0.00343	CcSEcCtD
Rufinamide—Leukopenia—Etoposide—sarcoma	0.000786	0.00341	CcSEcCtD
Rufinamide—ALB—testis—sarcoma	0.000771	0.0116	CbGeAlD
Rufinamide—Decreased appetite—Vincristine—sarcoma	0.000769	0.00334	CcSEcCtD
Rufinamide—Ataxia—Epirubicin—sarcoma	0.000768	0.00334	CcSEcCtD
Rufinamide—SCN10A—lymph node—sarcoma	0.000768	0.0116	CbGeAlD
Rufinamide—Somnolence—Mitoxantrone—sarcoma	0.000766	0.00333	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Vincristine—sarcoma	0.000764	0.00332	CcSEcCtD
Rufinamide—Fatigue—Vincristine—sarcoma	0.000763	0.00331	CcSEcCtD
Rufinamide—Convulsion—Etoposide—sarcoma	0.000761	0.0033	CcSEcCtD
Rufinamide—Dyspepsia—Mitoxantrone—sarcoma	0.000758	0.00329	CcSEcCtD
Rufinamide—Constipation—Vincristine—sarcoma	0.000756	0.00329	CcSEcCtD
Rufinamide—Diplopia—Doxorubicin—sarcoma	0.000756	0.00328	CcSEcCtD
Rufinamide—Decreased appetite—Mitoxantrone—sarcoma	0.000749	0.00325	CcSEcCtD
Rufinamide—Abdominal pain upper—Epirubicin—sarcoma	0.000746	0.00324	CcSEcCtD
Rufinamide—Fatigue—Mitoxantrone—sarcoma	0.000743	0.00323	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000742	0.00322	CcSEcCtD
Rufinamide—Breast disorder—Epirubicin—sarcoma	0.000738	0.00321	CcSEcCtD
Rufinamide—Constipation—Mitoxantrone—sarcoma	0.000737	0.0032	CcSEcCtD
Rufinamide—Hypersensitivity—Thiotepa—sarcoma	0.000735	0.00319	CcSEcCtD
Rufinamide—Nasopharyngitis—Epirubicin—sarcoma	0.000731	0.00317	CcSEcCtD
Rufinamide—Hypersensitivity—Dactinomycin—sarcoma	0.000729	0.00317	CcSEcCtD
Rufinamide—ALB—liver—sarcoma	0.000728	0.011	CbGeAlD
Rufinamide—Asthenia—Thiotepa—sarcoma	0.000716	0.00311	CcSEcCtD
Rufinamide—Infection—Etoposide—sarcoma	0.000712	0.00309	CcSEcCtD
Rufinamide—Ataxia—Doxorubicin—sarcoma	0.000711	0.00309	CcSEcCtD
Rufinamide—Asthenia—Dactinomycin—sarcoma	0.00071	0.00308	CcSEcCtD
Rufinamide—Influenza—Epirubicin—sarcoma	0.000706	0.00307	CcSEcCtD
Rufinamide—Pruritus—Thiotepa—sarcoma	0.000706	0.00307	CcSEcCtD
Rufinamide—Thrombocytopenia—Etoposide—sarcoma	0.000702	0.00305	CcSEcCtD
Rufinamide—SCN3A—lymph node—sarcoma	0.0007	0.0105	CbGeAlD
Rufinamide—Skin disorder—Etoposide—sarcoma	0.000696	0.00302	CcSEcCtD
Rufinamide—Abdominal pain upper—Doxorubicin—sarcoma	0.000691	0.003	CcSEcCtD
Rufinamide—Breast disorder—Doxorubicin—sarcoma	0.000683	0.00297	CcSEcCtD
Rufinamide—Anorexia—Etoposide—sarcoma	0.000683	0.00297	CcSEcCtD
Rufinamide—Diarrhoea—Thiotepa—sarcoma	0.000683	0.00296	CcSEcCtD
Rufinamide—Bronchitis—Epirubicin—sarcoma	0.000679	0.00295	CcSEcCtD
Rufinamide—Diarrhoea—Dactinomycin—sarcoma	0.000677	0.00294	CcSEcCtD
Rufinamide—Nasopharyngitis—Doxorubicin—sarcoma	0.000676	0.00294	CcSEcCtD
Rufinamide—CYP3A4—hematopoietic system—sarcoma	0.000669	0.0101	CbGeAlD
Rufinamide—Neutropenia—Epirubicin—sarcoma	0.00066	0.00287	CcSEcCtD
Rufinamide—Dysuria—Epirubicin—sarcoma	0.00066	0.00287	CcSEcCtD
Rufinamide—Dizziness—Thiotepa—sarcoma	0.00066	0.00286	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—sarcoma	0.000654	0.00284	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—sarcoma	0.000652	0.00283	CcSEcCtD
Rufinamide—Hypersensitivity—Vincristine—sarcoma	0.000652	0.00283	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—sarcoma	0.000639	0.00278	CcSEcCtD
Rufinamide—Somnolence—Etoposide—sarcoma	0.000637	0.00277	CcSEcCtD
Rufinamide—Hypersensitivity—Mitoxantrone—sarcoma	0.000635	0.00276	CcSEcCtD
Rufinamide—Asthenia—Vincristine—sarcoma	0.000635	0.00276	CcSEcCtD
Rufinamide—Vomiting—Thiotepa—sarcoma	0.000634	0.00275	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—sarcoma	0.000633	0.00275	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—sarcoma	0.00063	0.00274	CcSEcCtD
Rufinamide—Infestation—Epirubicin—sarcoma	0.00063	0.00274	CcSEcCtD
Rufinamide—Vomiting—Dactinomycin—sarcoma	0.000629	0.00273	CcSEcCtD
Rufinamide—Rash—Thiotepa—sarcoma	0.000629	0.00273	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—sarcoma	0.000629	0.00273	CcSEcCtD
Rufinamide—Dermatitis—Thiotepa—sarcoma	0.000628	0.00273	CcSEcCtD
Rufinamide—Headache—Thiotepa—sarcoma	0.000625	0.00271	CcSEcCtD
Rufinamide—Rash—Dactinomycin—sarcoma	0.000624	0.00271	CcSEcCtD
Rufinamide—Decreased appetite—Etoposide—sarcoma	0.000623	0.00271	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Etoposide—sarcoma	0.000619	0.00269	CcSEcCtD
Rufinamide—Asthenia—Mitoxantrone—sarcoma	0.000618	0.00268	CcSEcCtD
Rufinamide—Fatigue—Etoposide—sarcoma	0.000618	0.00268	CcSEcCtD
Rufinamide—Constipation—Etoposide—sarcoma	0.000613	0.00266	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—sarcoma	0.000611	0.00265	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—sarcoma	0.000611	0.00265	CcSEcCtD
Rufinamide—Diarrhoea—Vincristine—sarcoma	0.000605	0.00263	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—sarcoma	0.000604	0.00262	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—sarcoma	0.0006	0.00261	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—sarcoma	0.000596	0.00259	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—sarcoma	0.000594	0.00258	CcSEcCtD
Rufinamide—Nausea—Thiotepa—sarcoma	0.000593	0.00257	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—sarcoma	0.000591	0.00257	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—sarcoma	0.000591	0.00257	CcSEcCtD
Rufinamide—Diarrhoea—Mitoxantrone—sarcoma	0.000589	0.00256	CcSEcCtD
Rufinamide—Nausea—Dactinomycin—sarcoma	0.000588	0.00255	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—sarcoma	0.000586	0.00255	CcSEcCtD
Rufinamide—CYP2E1—lymphoid tissue—sarcoma	0.000586	0.00882	CbGeAlD
Rufinamide—Dizziness—Vincristine—sarcoma	0.000585	0.00254	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—sarcoma	0.000583	0.00253	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—sarcoma	0.000583	0.00253	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—sarcoma	0.000567	0.00246	CcSEcCtD
Rufinamide—Vomiting—Vincristine—sarcoma	0.000562	0.00244	CcSEcCtD
Rufinamide—ALB—lymph node—sarcoma	0.000559	0.00841	CbGeAlD
Rufinamide—Urinary tract disorder—Epirubicin—sarcoma	0.000558	0.00242	CcSEcCtD
Rufinamide—Rash—Vincristine—sarcoma	0.000558	0.00242	CcSEcCtD
Rufinamide—Dermatitis—Vincristine—sarcoma	0.000557	0.00242	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—sarcoma	0.000556	0.00241	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—sarcoma	0.000554	0.00241	CcSEcCtD
Rufinamide—Headache—Vincristine—sarcoma	0.000554	0.00241	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000551	0.00239	CcSEcCtD
Rufinamide—CYP2E1—tendon—sarcoma	0.000551	0.00829	CbGeAlD
Rufinamide—Epistaxis—Doxorubicin—sarcoma	0.00055	0.00239	CcSEcCtD
Rufinamide—Vomiting—Mitoxantrone—sarcoma	0.000548	0.00238	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—sarcoma	0.000547	0.00237	CcSEcCtD
Rufinamide—Rash—Mitoxantrone—sarcoma	0.000543	0.00236	CcSEcCtD
Rufinamide—Dermatitis—Mitoxantrone—sarcoma	0.000543	0.00236	CcSEcCtD
Rufinamide—Headache—Mitoxantrone—sarcoma	0.00054	0.00234	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—sarcoma	0.000528	0.00229	CcSEcCtD
Rufinamide—Hypersensitivity—Etoposide—sarcoma	0.000528	0.00229	CcSEcCtD
Rufinamide—Nausea—Vincristine—sarcoma	0.000525	0.00228	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—sarcoma	0.000525	0.00228	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—sarcoma	0.000524	0.00228	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—sarcoma	0.000517	0.00224	CcSEcCtD
Rufinamide—Asthenia—Etoposide—sarcoma	0.000514	0.00223	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—sarcoma	0.000513	0.00223	CcSEcCtD
Rufinamide—Nausea—Mitoxantrone—sarcoma	0.000512	0.00222	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—sarcoma	0.000511	0.00222	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—sarcoma	0.00051	0.00221	CcSEcCtD
Rufinamide—Pruritus—Etoposide—sarcoma	0.000507	0.0022	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—sarcoma	0.000495	0.00215	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—sarcoma	0.000492	0.00214	CcSEcCtD
Rufinamide—Diarrhoea—Etoposide—sarcoma	0.00049	0.00213	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—sarcoma	0.000489	0.00212	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—sarcoma	0.000485	0.00211	CcSEcCtD
Rufinamide—Back pain—Epirubicin—sarcoma	0.000476	0.00207	CcSEcCtD
Rufinamide—Dizziness—Etoposide—sarcoma	0.000474	0.00206	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—sarcoma	0.000472	0.00205	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—sarcoma	0.000471	0.00205	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—sarcoma	0.000464	0.00201	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—sarcoma	0.000458	0.00199	CcSEcCtD
Rufinamide—CYP2E1—testis—sarcoma	0.000456	0.00687	CbGeAlD
Rufinamide—Vomiting—Etoposide—sarcoma	0.000456	0.00198	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—sarcoma	0.000455	0.00198	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—sarcoma	0.000455	0.00198	CcSEcCtD
Rufinamide—Agitation—Epirubicin—sarcoma	0.000452	0.00196	CcSEcCtD
Rufinamide—Rash—Etoposide—sarcoma	0.000452	0.00196	CcSEcCtD
Rufinamide—Dermatitis—Etoposide—sarcoma	0.000451	0.00196	CcSEcCtD
Rufinamide—Headache—Etoposide—sarcoma	0.000449	0.00195	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—sarcoma	0.000442	0.00192	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—sarcoma	0.000441	0.00191	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—sarcoma	0.00044	0.00191	CcSEcCtD
Rufinamide—CYP2E1—liver—sarcoma	0.000431	0.00649	CbGeAlD
Rufinamide—Vision blurred—Doxorubicin—sarcoma	0.000429	0.00186	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—sarcoma	0.000426	0.00185	CcSEcCtD
Rufinamide—Nausea—Etoposide—sarcoma	0.000426	0.00185	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—sarcoma	0.000421	0.00183	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—sarcoma	0.000418	0.00182	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—sarcoma	0.000418	0.00181	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000416	0.00181	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—sarcoma	0.000409	0.00178	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—sarcoma	0.000408	0.00177	CcSEcCtD
Rufinamide—Infection—Epirubicin—sarcoma	0.000399	0.00173	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—sarcoma	0.000395	0.00171	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—sarcoma	0.000394	0.00171	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—sarcoma	0.000393	0.00171	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—sarcoma	0.00039	0.00169	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—sarcoma	0.000386	0.00168	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000385	0.00167	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—sarcoma	0.000383	0.00166	CcSEcCtD
Rufinamide—Infection—Doxorubicin—sarcoma	0.000369	0.0016	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—sarcoma	0.000364	0.00158	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—sarcoma	0.000364	0.00158	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—sarcoma	0.000363	0.00158	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—sarcoma	0.000361	0.00157	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—sarcoma	0.000357	0.00155	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—sarcoma	0.000354	0.00154	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—sarcoma	0.000354	0.00154	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—sarcoma	0.000349	0.00152	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000347	0.00151	CcSEcCtD
Rufinamide—CYP3A4—liver—sarcoma	0.000347	0.00522	CbGeAlD
Rufinamide—Fatigue—Epirubicin—sarcoma	0.000346	0.0015	CcSEcCtD
Rufinamide—Constipation—Epirubicin—sarcoma	0.000343	0.00149	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—sarcoma	0.000336	0.00146	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—sarcoma	0.00033	0.00143	CcSEcCtD
Rufinamide—SCN2A—Axon guidance—KDR—sarcoma	0.000329	0.00193	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—KDR—sarcoma	0.000329	0.00193	CbGpPWpGaD
Rufinamide—Dyspepsia—Doxorubicin—sarcoma	0.000327	0.00142	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—sarcoma	0.000323	0.0014	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000321	0.00139	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—sarcoma	0.00032	0.00139	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—sarcoma	0.000318	0.00138	CcSEcCtD
Rufinamide—SCN10A—Axon guidance—KDR—sarcoma	0.000317	0.00186	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—KDR—sarcoma	0.000317	0.00186	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—MMP2—sarcoma	0.000316	0.00185	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—KDR—sarcoma	0.000315	0.00185	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—CREB1—sarcoma	0.000314	0.00184	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFC—sarcoma	0.000313	0.00184	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—FOXO1—sarcoma	0.000308	0.00181	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—SRC—sarcoma	0.000307	0.0018	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CREB1—sarcoma	0.000302	0.00178	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—CREB1—sarcoma	0.0003	0.00176	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—VEGFA—sarcoma	0.000299	0.00175	CbGpPWpGaD
Rufinamide—Hypersensitivity—Epirubicin—sarcoma	0.000296	0.00129	CcSEcCtD
Rufinamide—SCN7A—Axon guidance—NRAS—sarcoma	0.000295	0.00173	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—FOXO1—sarcoma	0.000295	0.00173	CbGpPWpGaD
Rufinamide—SCN5A—L1CAM interactions—EGFR—sarcoma	0.000292	0.00172	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—MMP2—sarcoma	0.000292	0.00171	CbGpPWpGaD
Rufinamide—Asthenia—Epirubicin—sarcoma	0.000288	0.00125	CcSEcCtD
Rufinamide—SCN2A—Axon guidance—CREB1—sarcoma	0.000288	0.00169	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—CREB1—sarcoma	0.000288	0.00169	CbGpPWpGaD
Rufinamide—Pruritus—Epirubicin—sarcoma	0.000284	0.00123	CcSEcCtD
Rufinamide—SCN2A—Developmental Biology—FOXO1—sarcoma	0.000283	0.00166	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—FOXO1—sarcoma	0.000283	0.00166	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—MMP2—sarcoma	0.000282	0.00165	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—MMP2—sarcoma	0.000279	0.00164	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—CREB1—sarcoma	0.000278	0.00163	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—CREB1—sarcoma	0.000278	0.00163	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PTPRC—sarcoma	0.000277	0.00162	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CREB1—sarcoma	0.000277	0.00162	CbGpPWpGaD
Rufinamide—Diarrhoea—Epirubicin—sarcoma	0.000275	0.00119	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—sarcoma	0.000274	0.00119	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—SRC—sarcoma	0.000273	0.0016	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—FOXO1—sarcoma	0.000273	0.0016	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—FOXO1—sarcoma	0.000273	0.0016	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PLCG1—sarcoma	0.000271	0.00159	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—EGFR—sarcoma	0.000269	0.00158	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—MMP2—sarcoma	0.000268	0.00157	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—MMP2—sarcoma	0.000268	0.00157	CbGpPWpGaD
Rufinamide—Asthenia—Doxorubicin—sarcoma	0.000267	0.00116	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—VEGFA—sarcoma	0.000266	0.00156	CbGpPWpGaD
Rufinamide—Dizziness—Epirubicin—sarcoma	0.000266	0.00115	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—NRAS—sarcoma	0.000263	0.00154	CbGpPWpGaD
Rufinamide—Pruritus—Doxorubicin—sarcoma	0.000263	0.00114	CcSEcCtD
Rufinamide—SCN1A—Axon guidance—MMP2—sarcoma	0.000259	0.00152	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—MMP2—sarcoma	0.000259	0.00152	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—MMP2—sarcoma	0.000258	0.00151	CbGpPWpGaD
Rufinamide—Vomiting—Epirubicin—sarcoma	0.000255	0.00111	CcSEcCtD
Rufinamide—SCN9A—Developmental Biology—KDR—sarcoma	0.000255	0.0015	CbGpPWpGaD
Rufinamide—Diarrhoea—Doxorubicin—sarcoma	0.000254	0.0011	CcSEcCtD
Rufinamide—SCN7A—Axon guidance—KRAS—sarcoma	0.000254	0.00149	CbGpPWpGaD
Rufinamide—Rash—Epirubicin—sarcoma	0.000253	0.0011	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—sarcoma	0.000253	0.0011	CcSEcCtD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	0.000252	0.00148	CbGpPWpGaD
Rufinamide—Headache—Epirubicin—sarcoma	0.000252	0.00109	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—FLT1—sarcoma	0.00025	0.00147	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.00025	0.00147	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—SRC—sarcoma	0.00025	0.00147	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000247	0.00145	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PLCG1—sarcoma	0.000246	0.00144	CbGpPWpGaD
Rufinamide—Dizziness—Doxorubicin—sarcoma	0.000246	0.00107	CcSEcCtD
Rufinamide—SCN3A—Developmental Biology—KDR—sarcoma	0.000244	0.00143	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—VEGFA—sarcoma	0.000244	0.00143	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—CTNNB1—sarcoma	0.000242	0.00142	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—NRAS—sarcoma	0.000241	0.00141	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—EGFR—sarcoma	0.00024	0.00141	CbGpPWpGaD
Rufinamide—Nausea—Epirubicin—sarcoma	0.000239	0.00104	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—CXCR4—sarcoma	0.000236	0.00139	CbGpPWpGaD
Rufinamide—Vomiting—Doxorubicin—sarcoma	0.000236	0.00103	CcSEcCtD
Rufinamide—SCN2A—Developmental Biology—KDR—sarcoma	0.000234	0.00138	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KDR—sarcoma	0.000234	0.00138	CbGpPWpGaD
Rufinamide—Rash—Doxorubicin—sarcoma	0.000234	0.00102	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—sarcoma	0.000234	0.00102	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—ATF1—sarcoma	0.000234	0.00137	CbGpPWpGaD
Rufinamide—Headache—Doxorubicin—sarcoma	0.000233	0.00101	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—KRAS—sarcoma	0.000226	0.00133	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KDR—sarcoma	0.000226	0.00133	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KDR—sarcoma	0.000226	0.00133	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CREB1—sarcoma	0.000224	0.00131	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KDR—sarcoma	0.000223	0.00131	CbGpPWpGaD
Rufinamide—Nausea—Doxorubicin—sarcoma	0.000221	0.000959	CcSEcCtD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.00022	0.00129	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—EGFR—sarcoma	0.000219	0.00129	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—SRC—sarcoma	0.000219	0.00129	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—HRAS—sarcoma	0.000216	0.00127	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—CTNNB1—sarcoma	0.000216	0.00127	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CREB1—sarcoma	0.000214	0.00126	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CREB1—sarcoma	0.000214	0.00126	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—VEGFA—sarcoma	0.000213	0.00125	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—NRAS—sarcoma	0.000211	0.00124	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MMP2—sarcoma	0.000208	0.00122	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—KRAS—sarcoma	0.000207	0.00122	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CREB1—sarcoma	0.000206	0.00121	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CREB1—sarcoma	0.000206	0.00121	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—SRC—sarcoma	0.000202	0.00119	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MMP2—sarcoma	0.000199	0.00117	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CREB1—sarcoma	0.000198	0.00116	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CREB1—sarcoma	0.000198	0.00116	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—CTNNB1—sarcoma	0.000197	0.00116	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—VEGFA—sarcoma	0.000197	0.00116	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—CREB1—sarcoma	0.000195	0.00115	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—SRC—sarcoma	0.000195	0.00115	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—NRAS—sarcoma	0.000195	0.00114	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL2—sarcoma	0.000194	0.00114	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—SRC—sarcoma	0.000193	0.00114	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—HRAS—sarcoma	0.000192	0.00113	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—FOXO1—sarcoma	0.000192	0.00113	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—EGFR—sarcoma	0.000192	0.00113	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MMP2—sarcoma	0.000191	0.00112	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MMP2—sarcoma	0.000191	0.00112	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—VEGFA—sarcoma	0.00019	0.00112	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—VEGFA—sarcoma	0.000188	0.00111	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—NRAS—sarcoma	0.000188	0.0011	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—NRAS—sarcoma	0.000186	0.00109	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—SRC—sarcoma	0.000186	0.00109	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—SRC—sarcoma	0.000186	0.00109	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP2—sarcoma	0.000185	0.00108	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP2—sarcoma	0.000185	0.00108	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF1R—sarcoma	0.000183	0.00108	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP2—sarcoma	0.000182	0.00107	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—KRAS—sarcoma	0.000181	0.00106	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—VEGFA—sarcoma	0.000181	0.00106	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—VEGFA—sarcoma	0.000181	0.00106	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—SRC—sarcoma	0.000179	0.00105	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—SRC—sarcoma	0.000179	0.00105	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—NRAS—sarcoma	0.000179	0.00105	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—NRAS—sarcoma	0.000179	0.00105	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—SRC—sarcoma	0.000178	0.00105	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—EGFR—sarcoma	0.000177	0.00104	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—HRAS—sarcoma	0.000176	0.00103	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—FOXO1—sarcoma	0.000175	0.00102	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—VEGFA—sarcoma	0.000175	0.00102	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—VEGFA—sarcoma	0.000175	0.00102	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—IL2—sarcoma	0.000174	0.00102	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PDGFRB—sarcoma	0.000174	0.00102	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—VEGFA—sarcoma	0.000174	0.00102	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TEK—sarcoma	0.000174	0.00102	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—NRAS—sarcoma	0.000172	0.00101	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—NRAS—sarcoma	0.000172	0.00101	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—NRAS—sarcoma	0.000172	0.00101	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PDGFRA—sarcoma	0.000172	0.00101	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—EGFR—sarcoma	0.000171	0.001	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—EGFR—sarcoma	0.00017	0.000995	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—KRAS—sarcoma	0.000167	0.000983	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—EGFR—sarcoma	0.000163	0.000956	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—EGFR—sarcoma	0.000163	0.000956	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—KRAS—sarcoma	0.000162	0.000948	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—KRAS—sarcoma	0.00016	0.00094	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—CTNNB1—sarcoma	0.00016	0.000937	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KDR—sarcoma	0.000159	0.000933	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ANGPT2—sarcoma	0.000159	0.000933	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL2—sarcoma	0.000158	0.00093	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—EGFR—sarcoma	0.000157	0.000922	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—EGFR—sarcoma	0.000157	0.000922	CbGpPWpGaD
Rufinamide—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000157	0.000921	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—EGFR—sarcoma	0.000156	0.000918	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—HRAS—sarcoma	0.000154	0.000904	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—KRAS—sarcoma	0.000154	0.000903	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—KRAS—sarcoma	0.000154	0.000903	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—CTNNB1—sarcoma	0.000153	0.000897	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—KRAS—sarcoma	0.000148	0.000871	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—KRAS—sarcoma	0.000148	0.000871	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—KRAS—sarcoma	0.000148	0.000867	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—CTNNB1—sarcoma	0.000147	0.000861	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—CTNNB1—sarcoma	0.000147	0.000861	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KDR—sarcoma	0.000144	0.000848	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—SRC—sarcoma	0.000144	0.000847	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—HRAS—sarcoma	0.000142	0.000836	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—sarcoma	0.000142	0.000832	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—CTNNB1—sarcoma	0.000141	0.000831	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—CTNNB1—sarcoma	0.000141	0.000831	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—sarcoma	0.000141	0.000825	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CREB1—sarcoma	0.000139	0.000818	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—NRAS—sarcoma	0.000139	0.000815	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—SRC—sarcoma	0.000138	0.00081	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—HRAS—sarcoma	0.000137	0.000806	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—HRAS—sarcoma	0.000136	0.000799	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.000135	0.000792	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—sarcoma	0.000134	0.000789	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KIT—sarcoma	0.000133	0.000781	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—NRAS—sarcoma	0.000133	0.000781	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—NRAS—sarcoma	0.000133	0.00078	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—SRC—sarcoma	0.000133	0.000779	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—SRC—sarcoma	0.000133	0.000779	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—HRAS—sarcoma	0.000131	0.000768	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—HRAS—sarcoma	0.000131	0.000768	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP2—sarcoma	0.00013	0.000762	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—sarcoma	0.000129	0.000758	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—sarcoma	0.000129	0.000758	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—SRC—sarcoma	0.000128	0.000751	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—SRC—sarcoma	0.000128	0.000751	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—NRAS—sarcoma	0.000128	0.000749	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—NRAS—sarcoma	0.000128	0.000749	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFC—sarcoma	0.000128	0.000749	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CREB1—sarcoma	0.000127	0.000743	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—EGFR—sarcoma	0.000126	0.000743	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—HRAS—sarcoma	0.000126	0.00074	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—HRAS—sarcoma	0.000126	0.00074	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—SRC—sarcoma	0.000126	0.00074	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—HRAS—sarcoma	0.000126	0.000737	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TP53—sarcoma	0.000125	0.000733	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—sarcoma	0.000125	0.000731	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—sarcoma	0.000125	0.000731	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—NRAS—sarcoma	0.000123	0.000722	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—NRAS—sarcoma	0.000123	0.000722	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—sarcoma	0.000123	0.00072	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—NRAS—sarcoma	0.000121	0.000712	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—EGFR—sarcoma	0.000121	0.000711	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—EGFR—sarcoma	0.000121	0.00071	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—KRAS—sarcoma	0.000119	0.000701	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—EGFR—sarcoma	0.000116	0.000682	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—EGFR—sarcoma	0.000116	0.000682	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—KRAS—sarcoma	0.000114	0.000672	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—KRAS—sarcoma	0.000114	0.000671	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—EGFR—sarcoma	0.000112	0.000658	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—EGFR—sarcoma	0.000112	0.000658	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—EGFR—sarcoma	0.00011	0.000648	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—KRAS—sarcoma	0.00011	0.000645	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—KRAS—sarcoma	0.00011	0.000645	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—KRAS—sarcoma	0.000106	0.000622	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—KRAS—sarcoma	0.000106	0.000622	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MDM2—sarcoma	0.000105	0.000615	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—KRAS—sarcoma	0.000104	0.000612	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—HRAS—sarcoma	0.000102	0.000596	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLCG1—sarcoma	0.0001	0.000588	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—CTNNB1—sarcoma	9.95e-05	0.000584	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—HRAS—sarcoma	9.73e-05	0.000571	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—HRAS—sarcoma	9.72e-05	0.00057	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2—sarcoma	9.36e-05	0.000549	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—HRAS—sarcoma	9.33e-05	0.000548	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—HRAS—sarcoma	9.33e-05	0.000548	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCND1—sarcoma	9.12e-05	0.000536	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—JUN—sarcoma	9.11e-05	0.000535	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CTNNB1—sarcoma	9.04e-05	0.00053	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—HRAS—sarcoma	9e-05	0.000528	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—HRAS—sarcoma	9e-05	0.000528	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—SRC—sarcoma	8.99e-05	0.000528	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—HRAS—sarcoma	8.87e-05	0.000521	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—sarcoma	8.76e-05	0.000514	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NRAS—sarcoma	8.65e-05	0.000508	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SRC—sarcoma	8.17e-05	0.000479	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—sarcoma	7.96e-05	0.000467	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—EGFR—sarcoma	7.88e-05	0.000463	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRAS—sarcoma	7.86e-05	0.000461	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—KRAS—sarcoma	7.44e-05	0.000437	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	7.4e-05	0.000434	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—sarcoma	7.32e-05	0.00043	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—EGFR—sarcoma	7.16e-05	0.00042	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—sarcoma	6.76e-05	0.000397	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	6.45e-05	0.000379	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—sarcoma	6.33e-05	0.000371	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	6.29e-05	0.000369	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—sarcoma	6.01e-05	0.000353	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—sarcoma	5.75e-05	0.000337	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO2—sarcoma	5.57e-05	0.000327	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HBA1—sarcoma	5.54e-05	0.000325	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO2—sarcoma	4.79e-05	0.000281	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HBA1—sarcoma	4.76e-05	0.000279	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLCG1—sarcoma	4.73e-05	0.000277	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLCG1—sarcoma	4.06e-05	0.000238	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—sarcoma	3.81e-05	0.000224	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—sarcoma	3.33e-05	0.000195	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—sarcoma	3.24e-05	0.00019	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NRAS—sarcoma	3.2e-05	0.000188	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—sarcoma	2.75e-05	0.000162	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO2—sarcoma	2.58e-05	0.000152	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HBA1—sarcoma	2.57e-05	0.000151	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—sarcoma	2.45e-05	0.000144	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—sarcoma	2.34e-05	0.000137	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLCG1—sarcoma	2.19e-05	0.000129	CbGpPWpGaD
